美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MapLight Therapeutics, Inc.

18.49

+0.15000.82%

盤後：19.000.5100+2.76%19:42 EST

成交量：36.56萬

成交額：676.32萬

市值：8.07億

市盈率：-0.15

高：19.25

開：18.10

低：17.82

收：18.34

52周最高：20.86

52周最低：12.24

股本：4,364.14萬

流通股本：1,522.67萬

量比：1.00

換手率：2.40%

股息：- -

股息率：- -

每股收益(TTM):-121.4976

每股收益(LYR):-105.3781

淨資產收益率：--

總資產收益率：--

市淨率：-2.94

市盈率(LYR):-0.18

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

MapLight Therapeutics, Inc.

交易所：

NASDAQ

成立時間：

2018

員工人數：

114

公司地址：

800 Chesapeake Drive,Redwood City,California,United States

官網：

http://www.maplightrx.com

郵編：

94063

電話：

傳真：

- -

簡介：

MapLight Therapeutics, Inc.於2018年11月根據特拉華州法律註冊成立。該公司是一家臨床階段生物製藥公司，專註於改善患有衰弱性中樞神經系統 (CNS) 疾病的患者的生活。公司旨在解決患者缺乏針對特定神經迴路的藥物療法的問題。其發現平台旨在識別與疾病有因果關係的神經迴路，並針對這些神經迴路進行治療調控。其主要候選產品ML-007C-MA是一種固定劑量復方製劑，旨在治療精神分裂症和阿爾茨海默病引起的精神病，旨在激活中樞神經系統中特定的毒蕈鹼受體，同時最大限度地減少外周副作用。

董事

名稱

職位

Christopher A. Kroeger

Chief Executive Officer and Director

George Pavlov

Director

Jim Trenkle

Director

Maria Walker

Director

Nanna Lüneborg

Director

Robert Malenka

Director

Timothy Garnett

Director

股東

名稱

職位

Christopher A. Kroeger

Chief Executive Officer and Director

Vishwas Setia

Chief Financial Officer

Anatol Kreitzer

Chief Discovery Officer

Erin Pennock Foff

Chief Medical Officer

James Lillie

Chief Scientific Officer

Jonathan Gillis

Chief Administrative and Accounting Officer

Kristopher L. Hanson

General Counsel

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MPLT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MPLT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":18.49,"timestamp":1764968400000,"preClose":18.34,"halted":0,"volume":365580,"hourTrading":{"tag":"盘后","latestPrice":19,"preClose":18.49,"latestTime":"19:42 EST","volume":6331,"amount":117329.45,"timestamp":1764981763219},"delay":0,"floatShares":15226707,"shares":43641400,"eps":-121.49756,"marketStatus":"休市中","change":0.15,"latestTime":"12-05 16:00:00 EST","open":18.1,"high":19.2462,"low":17.82,"amount":6763240.60182,"amplitude":0.077764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-121.49756,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":18.34,"preHourTrading":{"tag":"盘前","latestPrice":17.8429,"preClose":18.34,"latestTime":"09:23 EST","volume":388,"amount":7020.8204240000005,"timestamp":1764944639663},"postHourTrading":{"tag":"盘后","latestPrice":19,"preClose":18.49,"latestTime":"19:42 EST","volume":6331,"amount":117329.45,"timestamp":1764981763219},"volumeRatio":0.9990622649035714},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","floatShares":15226707,"roa":"--","roe":"--","lyrEps":-105.378114,"volumeRatio":0.9990622649035714,"shares":43641400,"dividePrice":0,"high":19.2462,"amplitude":0.077764,"preClose":18.34,"low":17.82,"week52Low":12.24,"pbRate":"-2.94","week52High":20.8558,"institutionHeld":0,"latestPrice":18.49,"eps":-121.49756,"divideRate":0,"volume":365580,"delay":0,"ttmEps":-121.49756,"open":18.1,"prevYearClose":17,"prevWeekClose":13.63,"prevMonthClose":13.63,"prevQuarterClose":17,"fiveDayClose":13.63,"twentyDayClose":16.14,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MPLT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MPLT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MPLT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1763787600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MPLT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MPLT","date":"2025-12-05","current":-0.152184,"percent":0.178571,"low":-8.673514,"twenty":-7.714027,"median":-7.115398,"eighty":-6.435493,"high":-6.048324,"avg":-7.131757,"sd":0.698769,"marketCap":800383679},"quantilePoints":[{"date":"2025-10-31","current":-8.673514,"twenty":-8.310978,"median":-7.61973,"eighty":-7.489746,"marketCap":801692922},{"date":"2025-11-07","current":-7.620605,"twenty":-8.035178,"median":-7.644213,"eighty":-7.545137,"marketCap":704372551},{"date":"2025-11-14","current":-6.742394,"twenty":-7.98511,"median":-7.554503,"eighty":-7.23627,"marketCap":623199506},{"date":"2025-11-21","current":-6.274959,"twenty":-7.73109,"median":-7.394197,"eighty":-6.810384,"marketCap":579994498},{"date":"2025-11-28","current":-6.435493,"twenty":-7.639491,"median":-7.190943,"eighty":-6.54881,"marketCap":594832581},{"date":"2025-12-05","current":-7.783335,"twenty":-7.714027,"median":-7.115398,"eighty":-6.435493,"marketCap":800383679}],"updateTime":1765121717233},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":605975835,"yearFounded":2018,"employeeNum":114,"address":"800 Chesapeake Drive,Redwood City,California,United States","zipCode":"94063","officePhone":"617 984 6300"},"stockCompanyDetail":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":0.3566},{"period":"1month","weight":0.1556},{"period":"3month","weight":0.0876},{"period":"ytd","weight":0.0876}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"MapLight Therapeutics, Inc.於2018年11月根據特拉華州法律註冊成立。該公司是一家臨床階段生物製藥公司，專註於改善患有衰弱性中樞神經系統 (CNS) 疾病的患者的生活。公司旨在解決患者缺乏針對特定神經迴路的藥物療法的問題。其發現平台旨在識別與疾病有因果關係的神經迴路，並針對這些神經迴路進行治療調控。其主要候選產品ML-007C-MA是一種固定劑量復方製劑，旨在治療精神分裂症和阿爾茨海默病引起的精神病，旨在激活中樞神經系統中特定的毒蕈鹼受體，同時最大限度地減少外周副作用。","exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MPLT\",market:\"US\",,,undefined,":{"directors":[{"name":"Christopher A. Kroeger","position":"Chief Executive Officer and Director"},{"name":"George Pavlov","position":"Director"},{"name":"Jim Trenkle","position":"Director"},{"name":"Maria Walker","position":"Director"},{"name":"Nanna Lüneborg","position":"Director"},{"name":"Robert Malenka","position":"Director"},{"name":"Timothy Garnett","position":"Director"}],"executives":[{"name":"Christopher A. Kroeger","position":"Chief Executive Officer and Director"},{"name":"Vishwas Setia","position":"Chief Financial Officer"},{"name":"Anatol Kreitzer","position":"Chief Discovery Officer"},{"name":"Erin Pennock Foff","position":"Chief Medical Officer"},{"name":"James Lillie","position":"Chief Scientific Officer"},{"name":"Jonathan Gillis","position":"Chief Administrative and Accounting Officer"},{"name":"Kristopher L. Hanson","position":"General Counsel"}]}}}